Project Grant H79TI086810

Award Date 9/30/23
Completion Date 9/29/28
Dollars Obligated $2M
Federal Grant Program
93.243
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90016, USA
Similar Awards
The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA) Community Health Centers program (CFDA 93.224), awarded APLA Health & Wellness a $600,000 Project Grant in Year 1 and $500,000 in Year 2 to expand access to behavioral health services for low-income communities, the LGBTQ+ population, individuals living with or at risk for HIV, and the general low-income residents near APLA Health's service delivery sites in Los Angeles,...
The U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Center for Health Justice, Inc., a Los Angeles-based non-profit organization. The grant, titled "Project HOPE," aims to implement substance use disorder (SUD) and co-occurring mental health treatment and...
This $422,708,836 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will support the California Department of Health Care Services (DHCS) in expanding evidence-based treatment for opioid and stimulant use disorders across the state. The key objectives include: 1) expanding access to medication-assisted treatment, 2) addressing...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Erise Williams and Associates, Inc. to implement the "STL MADE: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at Risk for HIV/AIDS" project. The project aims to increase engagement in care for Black/African American individuals 18...
This $1,192,612 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a multidisciplinary effort to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: 1) conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; 2) use an...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the County of Alameda's Alameda County Health Care for the Homeless (HCH) Division. The grant will fund initiatives to reduce substance use-related mortality among people experiencing homelessness in Alameda County, California. Key activities include: Directly...
This $1,481,760 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate how methamphetamine (MA) exposure leads to inflammasome activation and altered immunity in people living with HIV (PWH) on antiretroviral therapy (ART). The key products and services to be delivered through this 5-year project include: 1) determining how MA exposure induces inflammasome activation and inflammation in PWH on...
This $600,000 Project Grant awarded by the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) federal grant program will support AAA Comprehensive Healthcare Inc., a non-profit community health center in North Hollywood, California, to expand mental health and substance use disorder (SUD) services. The key objectives are to 1) increase the number of patients receiving mental health services, and 2) increase the number of patients receiving SUD...
This $600,000 Project Grant awarded by the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) program will enable the North Orange County Regional Health Foundation to expand mental health, substance use disorder (SUD), and medication-assisted treatment (MOUD) services for their most vulnerable and underserved patient populations in central Orange County, California. Specifically, the funding will allow the organization to increase licensed...
This $600,000 Project Grant awarded by the Health Resources and Services Administration (HRSA) under the Community Health Centers program (CFDA 93.224) aims to expand access to mental health and substance use disorder treatment for adolescents and young adults in Oakland, California. The key goals are to: Hire and support additional licensed clinical social workers at the primary care site and school-based health centers to provide integrated mental health services within the medical home...

CLARE MATRIX MINORITY AIDS INITIATIVE (MAI) PROPOSAL - CLARE|MATRIX (C|M) AND ITS PARTNERS WILL BUILD ON ITS PAST SUCCESS AS A GRANTEE OF SAMHSA TARGETED CAPACITY EXPANSION: HIV FUNDING TO SERVE A CATCHMENT AREA OF MORE THAN 1MILLION INDIVIDUALS IN CALIFORNIA'S SOUTH AND CENTRAL LOS ANGELES AREA. THE POPULATION OF FOCUS FOR THIS PROJECT WILL BE PREDOMINANTLY AFRICAN AMERICAN AND LATINX ADULTS WITH OPIOID USE DISORDER (OUD) WHO ARE INJECTION DRUG USERS RESIDING IN LOS ANGELES COUNTY (LAC) AT RISK FOR HIV/AIDS AND VIRAL HEPATITIS. C|M'S MAI PROJECT WILL EXPAND ACCESS TO MAT FOR OUD AND SCREENING FOR HIV AND VIRAL HEPATITIS USING AN IN-HOUSE IMPLEMENTATION MODEL FOR OUD SERVICES. TREATMENT SERVICES FOR HIV AND VIRAL HEPATITIS WILL BE REFERRAL-BASED AND FACILITATED THROUGH MOAS. WITH THIS BLENDED APPROACH, C|M AND ITS PARTNERS WILL IMPACT THE DISPARATE RATES OF INJECTION DRUG USE AND HIV/HEPATITIS INFECTION RATES IN LAC, AN EHE PRIORITY JURISDICTION. BY THE END OF THE PROJECT, 430 PEOPLE WILL RECEIVE TREATMENT THAT WILL REDUCE DRUG USE, DRUG INJECTING, AND THE PRACTICE OF RISKY BEHAVIORS. THESE SERVICES WILL BE ENHANCED WITH ADDITIONAL SERVICES THAT INCREASE PARTICIPANT AWARENESS OF HIV AND VIRAL HEPATITIS STATUS, ACCESS TO TREATMENT, AND ACCESS TO ANTIRETROVIRAL THERAPY (ART) AND OTHER MEDICAL CARE. CARE FOR CO-OCCURRING MENTAL HEALTH DISORDERS WILL BE PROVIDED VIA SPECIALTY CARE AND CASE MANAGEMENT. C|M WILL ALSO IMPACT COMMUNITY RATES OF OVERDOSE AND INFECTIOUS DISEASE RELATED TO INJECTION DRUG USE THROUGH 260 HARM REDUCTION ENGAGEMENTS, 120 HEALTH AND WELLNESS GROUPS, AND 200 COMMUNITY EDUCATION AND AWARENESS EVENTS. THESE GOALS WILL BE ACCOMPLISHED BY A TEAM OF 3.15 CLINICAL, PROGRAM, AND CONTRACTED STAFF. A PROJECT DIRECTOR WILL ENSURE SUCCESSFUL IMPLEMENTATION, AND AN EVALUATOR WILL PROVIDE REGULAR REPORTS TO ENSURE ALL QUALITY AND ACCESS GOALS ARE MET.

Posted 9/18/23, 12:00 AM